TEMPEST THERAPEUTICS, INC. (TPST)
Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
Tempest Therapeutics Appoints Drake Richey and John Yee, MD, MPH to Board of Directors
Kuehn Law Encourages Investors of Ultragenyx Pharmaceutical Inc. to Contact Law Firm
Summit Plc - Summit Therapeutics to Participate in the 47th Annual Goldman Sachs Global Healthcare Conference
Knight-Swift Transportation Holdings Inc. Announces Retirement of Kevin Knight
Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions
OCS Investors Have Opportunity to Join Oculis Holding AG Fraud Investigation with the Schall Law Firm
Other Report or Announcement
Telesat announces results of 2026 Annual General Meeting of shareholders
Xos Makes Its GFX Debut with Electric Vehicles, Powertrain Technology, and Mobile Charging for Public Fleets
TOMI Expands European Footprint with New Regulatory Approvals for Binary Ionization Technology